Want to see HK:9887 full AI Analyst Report?
Nanjing Leads Biolabs Co., Ltd. Class H (9887) Stock Forecast & Price Target
9887 Analyst Ratings
Strong Buy
4Buy0Hold0Sell
Based on 4 analysts giving stock ratings to Nanjing Leads Biolabs Co., Ltd. Class H in the past 3 months
9887 Stock 12 Month Forecast
Average Price Target
HKD 96.43â–²(167.87% Upside)Based on 4 Wall Street analysts offering 12 month price targets for Nanjing Leads Biolabs Co., Ltd. Class H in the last 3 months. The average price target is HKD 96.43 with a high forecast of HKD 108.89 and a low forecast of HKD 83.34. The average price target represents a 167.87% change from the last price of HKD 36.00.
Past 12 Months12 Month ForecastDec2025Sep2026
HighHKD 108.89
AverageHKD 96.43
LowHKD 83.34
Highest Price TargetHighestHKD 108.89Average Price TargetHKD 96.43Lowest Price TargetLowestHKD 83.34
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Analyst Profile | Expert Firm | Price Target | Position | Upside / Downside | Action | Date | Follow | Article |
|---|---|---|---|---|---|---|---|---|
 Unknown AnalystNot Ranked | Morgan Stanley | HKD 79→HKD 93 | buy | 158.33%Upside | Upgraded | 09/16/26 | ||
| Unknown AnalystNot Ranked | Shenwan Hongyuan | HKD 108.89 | buy | 202.47%Upside | Reiterated | 09/10/26 | ||
| Andy Wang | CMB International Securities | HKD 100.50 | buy | 179.17%Upside | Reiterated | 09/03/26 | ||
| Unknown AnalystNot Ranked | SDIC Securities | HKD 83.34 | buy | 131.50%Upside | Reiterated | 09/03/26 | ||
| Unknown AnalystNot Ranked | CLSA | HKD 108 | buy | 200.00%Upside | Reiterated | 07/13/26 | ||
| Unknown AnalystNot Ranked | GF Securities | HKD 110.96 | buy | 208.22%Upside | Reiterated | 04/27/26 | ||
| Unknown AnalystNot Ranked | Orient Securities | HKD 81.01→HKD 103.06 | buy | 186.28%Upside | Reiterated | 04/21/26 | ||
| Unknown AnalystNot Ranked | Huafu Securities | HKD 101.90→HKD 140.75 | buy | 290.97%Upside | Reiterated | 04/14/26 | ||
| Unknown AnalystNot Ranked | Citic Securities | HKD 94 | buy | 161.11%Upside | Reiterated | 12/01/25 | ||
| Unknown AnalystNot Ranked | Cinda International Research Limited | HKD 103.56 | buy | 187.67%Upside | Reiterated | 11/02/25 |
| Analyst Profile | Date | Price Target | Position | Upside / Downside | Action | Follow | Article | Expert Firm |
|---|---|---|---|---|---|---|---|---|
| Unknown AnalystNot Ranked | 09/16/26 | HKD 79→HKD 93 | buy | 158.33%Upside | Upgraded | Morgan Stanley | ||
| Unknown AnalystNot Ranked | 09/10/26 | HKD 108.89 | buy | 202.47%Upside | Reiterated | Shenwan Hongyuan | ||
| Andy Wang | 09/03/26 | HKD 100.50 | buy | 179.17%Upside | Reiterated | CMB International Securities | ||
| Unknown AnalystNot Ranked | 09/03/26 | HKD 83.34 | buy | 131.50%Upside | Reiterated | SDIC Securities | ||
| Unknown AnalystNot Ranked | 07/13/26 | HKD 108 | buy | 200.00%Upside | Reiterated | CLSA | ||
| Unknown AnalystNot Ranked | 04/27/26 | HKD 110.96 | buy | 208.22%Upside | Reiterated | GF Securities | ||
| Unknown AnalystNot Ranked | 04/21/26 | HKD 81.01→HKD 103.06 | buy | 186.28%Upside | Reiterated | Orient Securities | ||
| Unknown AnalystNot Ranked | 04/14/26 | HKD 101.90→HKD 140.75 | buy | 290.97%Upside | Reiterated | Huafu Securities | ||
| Unknown AnalystNot Ranked | 12/01/25 | HKD 94 | buy | 161.11%Upside | Reiterated | Citic Securities | ||
| Unknown AnalystNot Ranked | 11/02/25 | HKD 103.56 | buy | 187.67%Upside | Reiterated | Cinda International Research Limited |
Stocks with the Highest Top Analyst Consensus in the General Sector
Best Analysts Covering Nanjing Leads Biolabs Co., Ltd. Class H
3 Months
Success Rate0/2 ratings generated profit
0%
Average Return
-39.30%
Copying Andy Wang's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of -39.30% per trade.
1 Year
Success Rate0/2 ratings generated profit
0%
Average Return
-47.65%
Copying Andy Wang's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -47.65% per trade.
2 Years
Success Rate0/2 ratings generated profit
0%
Average Return
-47.65%
Copying Andy Wang's trades and holding each position for 2 Years would result in 0.00% of your transactions generating a profit, with an average return of -47.65% per trade.
9887 Analyst Recommendation Trends
| Rating | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 4 | 3 |
| Buy | 2 | 0 | 0 | 2 | 2 |
| Hold | 1 | 2 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 4 | 3 | 3 | 7 | 5 |
In the current month, 9887 has received 5 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 9887 average Analyst price target in the past 3 months is 96.43.
9887 Financial Forecast
9887 Stock Forecast FAQ
What is HK:9887’s average 12-month price target, according to analysts?
Based on analyst ratings, Nanjing Leads Biolabs Co., Ltd. Class H’s 12-month average price target is HK$96.43.
What is HK:9887’s upside potential, based on the analysts’ average price target?
Nanjing Leads Biolabs Co., Ltd. Class H has 167.87% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Nanjing Leads Biolabs Co., Ltd. Class H a Buy, Sell or Hold?
Nanjing Leads Biolabs Co., Ltd. Class H has a consensus rating of Strong Buy, which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is Nanjing Leads Biolabs Co., Ltd. Class H’s share price target?
The average share price target for Nanjing Leads Biolabs Co., Ltd. Class H is HK$96.43. This is based on 4 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is HK$108.89, and the lowest forecast is HK$83.34. The average share price target represents a 167.87% increase from the current price of HK$36.
What do analysts say about Nanjing Leads Biolabs Co., Ltd. Class H?
Nanjing Leads Biolabs Co., Ltd. Class H’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Street analysts.
How can I buy shares of Nanjing Leads Biolabs Co., Ltd. Class H?
To buy shares of HK:9887, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.